191 related articles for article (PubMed ID: 15882432)
21. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
22. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.
Deng YH; He HY; Zhang BS
J Microbiol Immunol Infect; 2014 Feb; 47(1):48-56. PubMed ID: 23357605
[TBL] [Abstract][Full Text] [Related]
24. Recombinant BCG::Rv2645 elicits enhanced protective immunity compared to BCG in vivo with induced ISGylation-related genes and Th1 and Th17 responses.
Luo W; Qu Z; Zhang L; Xie Y; Luo F; Tan Y; Pan Q; Zhang XL
Vaccine; 2018 May; 36(21):2998-3009. PubMed ID: 29681409
[TBL] [Abstract][Full Text] [Related]
25. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
[TBL] [Abstract][Full Text] [Related]
26. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C
Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320
[TBL] [Abstract][Full Text] [Related]
27. Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.
Henao-Tamayo M; Obregón-Henao A; Creissen E; Shanley C; Orme I; Ordway DJ
Clin Vaccine Immunol; 2015 Jan; 22(1):91-8. PubMed ID: 25392011
[TBL] [Abstract][Full Text] [Related]
28. Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis.
Bao L; Chen W; Zhang H; Wang X
Infect Immun; 2003 Apr; 71(4):1656-61. PubMed ID: 12654778
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein.
Lu J; Wang C; Zhou Z; Zhang Y; Cao T; Shi C; Chen Z; Chen L; Cai C; Fan X
Clin Dev Immunol; 2011; 2011():617892. PubMed ID: 21461375
[TBL] [Abstract][Full Text] [Related]
30. Recombinant BCG-Rv1767 amount determines, in vivo, antigen-specific T cells location, frequency, and protective outcome.
Speranza V; Colone A; Cicconi R; Palmieri G; Giovannini D; Grassi M; Mattei M; Sali M; Delogu G; Andreola F; Colizzi V; Mariani F
Microb Pathog; 2010 May; 48(5):150-9. PubMed ID: 20219669
[TBL] [Abstract][Full Text] [Related]
31. Influence of advanced age on Mycobacterium bovis BCG vaccination in guinea pigs aerogenically infected with Mycobacterium tuberculosis.
Komine-Aizawa S; Yamazaki T; Yamazaki T; Hattori S; Miyamoto Y; Yamamoto N; Haga S; Sugitani M; Honda M; Hayakawa S; Yamamoto S
Clin Vaccine Immunol; 2010 Oct; 17(10):1500-6. PubMed ID: 20685935
[TBL] [Abstract][Full Text] [Related]
32. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
[TBL] [Abstract][Full Text] [Related]
33. rBCG30-induced immunity and cross-protection against Mycobacterium leprae challenge are enhanced by boosting with the Mycobacterium tuberculosis 30-kilodalton antigen 85B.
Gillis TP; Tullius MV; Horwitz MA
Infect Immun; 2014 Sep; 82(9):3900-9. PubMed ID: 25001602
[TBL] [Abstract][Full Text] [Related]
34. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
35. Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.
Liang J; Teng X; Yuan X; Zhang Y; Shi C; Yue T; Zhou L; Li J; Fan X
Mol Immunol; 2015 Aug; 66(2):392-401. PubMed ID: 25974877
[TBL] [Abstract][Full Text] [Related]
36. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
Goonetilleke NP; McShane H; Hannan CM; Anderson RJ; Brookes RH; Hill AV
J Immunol; 2003 Aug; 171(3):1602-9. PubMed ID: 12874255
[TBL] [Abstract][Full Text] [Related]
37. Comparison of BCG prime-DNA booster and rBCG regimens for protection against tuberculosis.
Tan K; Liang J; Teng X; Wang X; Zhang J; Yuan X; Fan X
Hum Vaccin Immunother; 2014; 10(2):391-8. PubMed ID: 24192709
[TBL] [Abstract][Full Text] [Related]
38. Accelerated induction of mycobacterial antigen-specific CD8+ T cells in the Mycobacterium tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette-Guérin.
Begum D; Umemura M; Yahagi A; Okamoto Y; Hamada S; Oshiro K; Matsuzaki G
Immunology; 2009 Dec; 128(4):556-63. PubMed ID: 19930045
[TBL] [Abstract][Full Text] [Related]
39. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
[TBL] [Abstract][Full Text] [Related]
40. Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein.
Shi C; Chen L; Chen Z; Zhang Y; Zhou Z; Lu J; Fu R; Wang C; Fang Z; Fan X
Vaccine; 2010 Jul; 28(32):5237-44. PubMed ID: 20538090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
